欢迎来到天天文库
浏览记录
ID:53739653
大小:214.44 KB
页数:3页
时间:2020-04-21
《ⅠB-ⅡA期宫颈癌术后化疗后放疗时使用顺铂增敏化疗能够提高远期生存率-论文.pdf》由会员上传分享,免费在线阅读,更多相关内容在应用文档-天天文库。
1、第47卷第3期哈尔滨医科大学学报Vo1.47,No.32013年6月JOURNALOFHARBINMEDICALUNIVERSITYJun.,2013275IB一ⅡA期宫颈癌术后化疗后放疗时使用顺铂增敏化疗能够提高远期生存率孙静,李奇,张美丽,杨姗姗,张云艳(哈尔滨医科大学附属第三医院妇放科,黑龙江哈尔滨150081)[摘要]目的探讨在IB-HA期宫颈癌术后化疗后具有高危因素的患者放疗中使用顺铂增敏化疗是否对远期生存率有影响。方法将114例接受宫颈癌根治术并在术后进行2~3周期PF方案化疗的具有高危因素的IB·ⅡA期宫颈癌患者
2、分为两组:即在术后放疗中使用顺铂周次增敏化疗组(A组)和未使用顺铂周次增敏化疗组(B组),分别进行回颐洼生存分析。结果A、B两组5年无病生存率分别是66.2%.4-6.2%、53.3%.4-7.2%,5年总生存率分别是48.O%.4-6.1%、55.5%±7.2%。A、B两个治疗组在无病生存率和总生存率相比均有统计学差异(P=0.012;尸:0.048)。结论IB.ⅡA期宫颈癌术后化疗后具有高危因素的患者在放疗时同步行顺铂周次化疗可以起到增敏的作用并可提高远期生存率。[关键词]宫颈癌;放射治疗;顺铂;增敏化疗;远期生存率[中图
3、分类号]R737.33[文献标识码]A[文章编号]1000—1905(2013)03—0275—03Sensitizationofcisplatintochemotherapycombinedwithpostoperativeradio-therapyimprovelong-termsurvivalofpatientsthcervicalcancerstageIB-ⅡASUNJing,LIQi,ZHANGMei-li,YANGShan—shan,ZHANGYun—yan(DepartmentofGynecologicBrach
4、ytherapy,TheThirdAffiliatedHospitalofHarbinMedicalUni—versity,Harbin150081,China)Abstract:ObjectiveToinvestigatethatwhetherutilizingcisplatininsensitizationtothera-diotherapyofhigh--riskpatientafterthechemotherapyofstageIB-IIAradicalsurgerywouldhaveanimpactOllthelon
5、g—termsurvivalrate.MethodsOnehundredandfourteenhigh—riskstageIB-I/Apatientswhohaveundergoneradicalsurgeryforcervicalcancerandthe2—3sessionsofpost—surgeryPFprogramsforchemotherapywereselectedandderidedintotwogroups:Thosewhounderwentweeklycisplatininsensitizationinthe
6、radiotherapyaftertheirsurgery(groupA)andthosewhodidn’t(groupB).ResultsThe5-yeardisease—freesurviv—al(DFS)ofgroupAandgroupBwere66.2%±6.2%,53.3%±7.2%,respectively.The5-yearoverallsurvival(OS)ofgroupAandgroupBwere68.0%±6.1%,55.5%±7.2%,respectively.Twogroupshadstatistic
7、alsignificanceinDFSandOS(P=0.012<0.05;P=0.048<0.051.ConclusionUtilizingeisplatinweeklyinthechemotherapycombinedwithra—diotherapyafterstageIB.·IIAsurgerywouldenablesensitizationandimprovethelong·-termsurvivalrateofeervicalcancer.Keywords:cervicalcancer;radiationthera
8、py;cisplatin;sensitizationtochemotherapy;long—termsurviva1[收稿日期]2012—11—15[基金项目]哈尔滨市科技创新人才研究专项资金项目(2Ol1RFQYS079)[作者简介]孙静(1986一),女,黑龙江哈尔滨人,
此文档下载收益归作者所有